Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway.
Zhang X, Wang S, Wang H, Cao J, Huang X, Chen Z, Xu P, Sun G, Xu J, Lv J, Xu Z. · 2019
Read Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. by Zhang X, Wang S, Wang H, Cao J, Huang X, Chen Z, Xu P, Sun G, Xu J, Lv J, Xu Z. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6360801.txt.
Introduction
Zhang and co-authors report a research article in Molecular Cancer on a circular RNA in stomach cancer. The RNA, called circNRIP1, is found at higher levels in gastric cancer tissue. Circular RNAs can act as sponges that soak up smaller RNAs.
Tests show circNRIP1 soaks up miR-149-5p, a small RNA that normally holds back growth. Freeing the AKT1 and mTOR signals then lets cancer cells grow and move. Blocking circNRIP1 slowed tumor traits in cell tests. The authors present this RNA chain as a driver of gastric cancer spread. It may also serve as a target for future drugs.
Catalog record
| CREATOR | Zhang X, Wang S, Wang H, Cao J, Huang X, Chen Z, Xu P, Sun G, Xu J, Lv J, Xu Z. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 86 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway By Xing Zhang, Sen Wang, Haixiao Wang, Jiacheng Cao, Xiaoxu Huang, Zheng Chen, Penghui Xu, Guangli Sun, Jianghao Xu, Jialun Lv, Zekuan Xu Published in: Molecular Cancer DOI: 10.1186/s12943-018-0935-5 ABSTRACT Background CircRNA has emerged as a new non-coding RNA that plays crucial roles in tumour initiation and development. ‘MiRNA sponge’ is the most reported role played by circRNAs in many tumours. The AKT/mTOR axis is a classic signalling pathway in cancers that sustains energy homeostasis through energy production activities, such as the Warburg effect, and blocks catabolic activities, such as autophagy. Additionally, the AKT/mTOR axis exerts a positive effect on EMT, which promotes tumour metastasis. Methods We detected higher circNRIP1 expression in gastric cancer by performing RNA-seq analysis. We verified the tumour promotor role of circNRIP1 in gastric cancer cells through a series of biological function assays. We then used a pull-down assay and dual-luciferase reporter assay to identify the downstream miR-149-5p of circNRIP1. Western blot analysis and immunofluorescence assays were performed to demonstrate that the circNRIP1-miR-149-5p-AKT1/mTOR axis is responsible for the altered metabolism in GC cells and promotes GC development. We then adopted a co-culture system to trace circNRIP1 transmission via exosomal communication and RIP experiments to determine that quaking regulates circNRIP1 expression. Finally, we confirmed the tumour suppressor role of microRNA-133a-3p in vivo in PDX mouse models. Results We discovered that knockdown of circNRIP1 successfully blocked proliferation, migration, invasion and the expression level of AKT1 in GC cells. MiR-149-5p inhibition phenocopied the overexpression of circNRIP1 in GC cells, and overexpression of miR-149-5p blocked the malignant behaviours of circNRIP1. Moreover, it was proven that circNRIP1 can be transmitted by exosomal communication between GC cells, and exosomal circNRIP1 promoted tumour metastasis in vivo. We also demonstrated that quaking can promote circNRIP1 transcription. In the final step, the tumour promotor role of circNRIP1 was verified in PDX models. Conclusions We proved that circNRIP1 sponges miR-149-5p to affect the expression level of AKT1 and eventually acts as a tumour promotor in GC. Electronic supplementary material The online version of this article (10.1186/s12943-018-0935-5) contains supplementary material, which is available to authorized users. BACKGROUND Gastric cancer (GC), also called stomach adenocarcinoma, has raised societal concerns worldwide, especially in East Asian countries in recent years. GC ranks as the fourth most frequent cancer and the third leading cause of cancer mortality worldwide according to the GLOBOCAN database [1–3]. Although many advancements have been achieved in terms of diagnostic methods and surgical procedures, the overall survival of GC patients has remained largely unsatisfactory in recent years. The 5-year overall survival is less than 30% in most countries [4]. The complexity of GC treatment lies in its heterogeneity within tumour tissues, not only due to genetic but also epigenetic alterations. Therefore, there is an urgent need to gain an in-depth understanding of the molecular mechanisms explaining GC initiation and development. It has been reported that non-coding RNAs regulate the initiation and development of GC. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are two major non-coding RNAs in tumour biology that have mainly been investigated due to their crucial roles [5–7]. CircRNA has emerged as a new non-coding RNA that is important in tumour initiation and development [8–10]. CircRNAs within eukaryotic cells were discovered 40 years ago. However, circRNAs are not properly understood and were identified as incorrect gene rearrangements and splicing errors until recently [11]. More functional circRNAs have been discovered thanks to high-throughput sequencing analysis and bioinformatic methods. CircRNAs are derived basically from the exons of their parental genes, although intronic and exonic-intronic circRNAs might sometimes occur [12, 13]. Exonic circRNAs are covalently connected and are structured in a heat-to-tail closed loop [14]. This circular structure is responsible for its stable existence and abundance in GC tissues, which makes circular RNAs themselves hallmarks for the diagnosis and prognosis of GC. Moreover, circRNAs have been reported to have many important roles, including as protein sponges [15, 16], in translation [17, 18] and as miRNA sponges [19]. ‘miRNA sponge’ is the most commonly reported role of circRNAs in many tumours [20, 21]. Many RNA transcripts share binding sites with miRNAs, and they compete with one another to act as competing endogenous RNAs (ceRNAs) to further regulate tumour development [22, 23]. CircRNAs assume the role of ceRNAs by acting as miRNA sponges in many tumours [24]. For example, circHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells [25]; additionally, the circular RNA profile of circPVT1 identifies it as a proliferative factor and prognostic marker in gastric cancer, and circular RNA MTO1 acts as the sponge of miR-9 to suppress hepatocellular carcinoma progression [26]. However, some researchers still argue that not all miRNAs targeted by circRNAs are suppressed, and current ceRNA validation methods are limited [11]. It has been reported that mTOR acts as downstream molecule of AKT1, and the AKT/mTOR pathway is one of the classic signalling pathways to mediate tumour metabolic homeostasis, which is beneficial for tumour growth and metastasis [27]. The AKT/mTOR axis sustains energy homeostasis through energy production activities, such as the Warburg effect, to satisfy the proliferation needs of GC cells [28]. mTORC1 (mTOR complex consisting of mTORC1 and mTORC2) is reported to accelerate tumour growth by promoting a shift to the Warburg effect, which likely facilitates the incorporation of nutrients into new bio-products to sustain the highly proliferative character of GC cells. mTORC1 facilitates the expression level of the transcription factor HIF1α, which increases the translation of several glycolytic enzymes, such as phospho-fructo kinase (PFK)]. Additionally, the AKT/mTOR axis enables anabolic metabolism, such as protein synthesis, and blocks catabolic activities, such as autophagy, to ultimately favour cell growth in GC [29, 30]. mTORC1 promotes cell growth by suppressing catabolic activities, including autophagy, to slow the aging of GC cells. mTORC1 phosphorylates ULK1 to prevent it from being activated by AMPK, a key activator of autophagy. Autophagy inhibition is also of great importance for the well vascularized condition of GC tumours. Additionally, the AKT/mTOR axis is also reported to exert a positive role in EMT, promoting tumour metastasis. Exosomes are reported to mediate the molecular communication and material transfer between primary tumour sites and distant metastasis sites [31, 32]. Exosomal communication maintains a very close relationship with tumour cell migration and invasion by regulating a series of cellular activities, including EMT [33, 34]. Many miRNAs, lncRNAs and circRNAs are reported to promote or suppress tumours via exosomes. In our study, we proved that circNRIP1 sponges miR-149-5p to affect the expression level of AKT1 and eventually acts as a tumour promotor in GC. CircNRIP1 can alter metabolism and autophagy through the AKT1/mTOR axis and promote tumour metastasis through exosome communication. In conclusion, targeting circNRIP1 to explore therapeutic methods is very promising for future research. METHODS Tissue specimens Tumour tissues and adjacent normal stomach mucosa tissues were collected from GC patients who received radical gastrectomy at the Department of Gastrointestinal Surgery, the First Affiliated Hospital of Nanjing Medical University, from 2013 to 2017. All patients did not receive radiotherapy and chemotherapy before surgery. All specimens were collected under the guidance of the HIPAA protocol and supervised by the